| Tag | Content |
|---|
EnhancerAtlas ID | HS182-11123 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr19:18419710-18420480 |
Target genes | | Number: 18 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr19:18420445-18420456 | TCTTCCCGCCC | - | 6.14 | | ZNF263 | MA0528.1 | chr19:18420284-18420305 | GGAGGCGCAGTGAGAGGAGGG | + | 6.02 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_01679 | chr19:18413437-18420591 | Aorta | | SE_11066 | chr19:18411381-18419855 | CD20 | | SE_24690 | chr19:18418803-18423834 | Colon_Crypt_3 | | SE_52990 | chr19:18413901-18423828 | Small_Intestine | | SE_54160 | chr19:18413595-18420662 | Spleen | | SE_61915 | chr19:18389769-18420206 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I018309 | chr19 | 18420357 | 18423714 |
|
Enhancer Sequence | CCTGCAGAGC AGCCAGAGAA AACCCCCCAC TTCCCTAGGT AGGACCCGAC CCACTCTCTC 60
AACAACCTTG ACCCCAACTA CTGGGAAGGA GCCAGGCCGG GGACCCCAGA GGCCCCACCC 120
ACCCTGAGAT CCCCAAAGCT CCCTGCCTGG AGTACTATCC CTGCCCCTCC CTCGGGCTCA 180
CTCCTGACCA CCTCGTGAGC CTGCACAGAA TTGGCGCCTG GGGCCTTCCG GGGGCAGCCA 240
TGCCGTGCTG CAAGCCCCCA GGCTGGCACC TGAGCCCAGC ACACAGGCAG TGCCCATGGA 300
TGGCAGAAGC AAAGCCCAGG TCCCCCCGAG AACACAGAGC TGGGGACAGA GAGGTGAGGA 360
AGGGCAGGGG CTACAGATGG CCCCTGGGCC TAACAAATGG AATTTTATGC CAATTCATCA 420
TCTCCGGTGG GGGCGGGCGA CCTTGGCTCT GGATAGAGCC ACGCCAGGTT CCAAGTGGAG 480
TTGCCAGCGG CCTGGACAGA TGGGCACCAC CATACCCTCT CAGAGGGGAA ACTGAGGCTT 540
GGGGAGGTGA CTTGATGTGC CCTGAGGACC GCCAGGAGGC GCAGTGAGAG GAGGGCTGAG 600
TCCCAGGTCT CGGGGCTCCT CTGCCTGGGC CTCGGCTCAT GGCCAAGGAC CAGGAGGGGG 660
GCCCGGGAGG GTTGGGAGGC TCCGAGGCAG CGCTGCAAGG GCAACCCCAA GAAGGAGGGA 720
TGCCACGTGT GGCTGTCTTC CCGCCCCAGG TACGTCCACT GGAGAGGGGA 770
|
